80947-0-1.jpg)
Abstract
To assess the role of homœopathic medicines in the treatment of the asymptomatic phase
of HIV infection, a pilot research study was undertaken by the Central Council for
Research in Homœopathy (India) starting in May 1989. 129 symptomatic HIV carriers
(120 male and 9 female) were treated with homœopathic medicines on the basis of the
individuals' constitutional (both mental/emotional and physical) characteristics.
The medicines were prescribed in potencies varying from 30 CH to 10M and in varying
dosage, depending on the age and constitution of the individual patients. 12 of the
patients studied have reverted back to negative serology for HIV antibodies after
treatment varying from 3 to 16 months (mean duration of treatment between entry and
reversal of seroconversion for HIV antibodies 7.25 months). All patients who continue
to remain symptom free are receiving follow-up treatment. Efforts are being made to
evaluate their haematological and immunological status in detail.
Key Words
Homœopathy - HIV infection - Anti-HIV antibodies
